12.03.25 MDL count continued to increase More new cases were added to the Wegovy MDL, with 2,947 plaintiffs as of December 2, 2025
Sources Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients Reuters May 29, 2026 Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes: A Randomized Clinical Trial ACP Journals May 26, 2026 A causal link between autoantibodies and neurological symptoms in long Covid Cell May 28, 2026
To determine which revolutionary GLP-1 therapy or combination of therapies, including supporting peptides and metabolic protocols is right for your health plan, Schedule your consultation with Dr
& Boulton, A
Several studies have investigated the potential neuroprotective effects of SF in various models of diabetes-induced cognitive impairment
It is best to stick to the recommended dose of one capsule per day to avoid too much caffeine